Here, we assessed whether LAT1 is upregulated during the progression of thyroid cancer and whether the inhibition of LAT1 by a potent and selective LAT1 inhibitor would reduce thyroid cancer growth both in vitro and in vivo. The gene discussed is SLC7A5; the disease is thyroid gland carcinoma.